CA2211174A1 - Specific binding materials - Google Patents
Specific binding materialsInfo
- Publication number
- CA2211174A1 CA2211174A1 CA002211174A CA2211174A CA2211174A1 CA 2211174 A1 CA2211174 A1 CA 2211174A1 CA 002211174 A CA002211174 A CA 002211174A CA 2211174 A CA2211174 A CA 2211174A CA 2211174 A1 CA2211174 A1 CA 2211174A1
- Authority
- CA
- Canada
- Prior art keywords
- target
- binding material
- specific binding
- shape
- size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 89
- 230000009870 specific binding Effects 0.000 title claims abstract description 44
- 239000013077 target material Substances 0.000 claims abstract description 38
- 244000005700 microbiome Species 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 7
- 108091007433 antigens Proteins 0.000 claims abstract description 7
- 102000036639 antigens Human genes 0.000 claims abstract description 7
- 239000011324 bead Substances 0.000 claims description 50
- 229920000642 polymer Polymers 0.000 claims description 32
- 230000027455 binding Effects 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 22
- 241000894007 species Species 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 239000012074 organic phase Substances 0.000 claims description 6
- -1 perfluoro group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 238000010406 interfacial reaction Methods 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 241000894006 Bacteria Species 0.000 description 33
- 239000000243 solution Substances 0.000 description 23
- 239000007993 MOPS buffer Substances 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000003756 stirring Methods 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229920000083 poly(allylamine) Polymers 0.000 description 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 7
- 241000186781 Listeria Species 0.000 description 7
- 239000004952 Polyamide Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 229920002647 polyamide Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- PWAXUOGZOSVGBO-UHFFFAOYSA-N adipoyl chloride Chemical compound ClC(=O)CCCCC(Cl)=O PWAXUOGZOSVGBO-UHFFFAOYSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 5
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 5
- 229960005542 ethidium bromide Drugs 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- 108090001090 Lectins Proteins 0.000 description 4
- 102000004856 Lectins Human genes 0.000 description 4
- 241000186779 Listeria monocytogenes Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000002523 lectin Substances 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 239000010702 perfluoropolyether Substances 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 3
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UBOXGVDOUJQMTN-UHFFFAOYSA-N 1,1,2-trichloroethane Chemical compound ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 2
- 102100022094 Acid-sensing ion channel 2 Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101000901079 Homo sapiens Acid-sensing ion channel 2 Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- QLDHWVVRQCGZLE-UHFFFAOYSA-N acetyl cyanide Chemical compound CC(=O)C#N QLDHWVVRQCGZLE-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- FYYZTOOGFNLGII-UHFFFAOYSA-N (1,6-dihydroxy-1-prop-2-enoyloxyhexyl) prop-2-enoate Chemical compound OCCCCCC(O)(OC(=O)C=C)OC(=O)C=C FYYZTOOGFNLGII-UHFFFAOYSA-N 0.000 description 1
- ZKVMMSGRDBQIOQ-UHFFFAOYSA-N 1,1,2-trichloro-1-fluoroethane Chemical compound FC(Cl)(Cl)CCl ZKVMMSGRDBQIOQ-UHFFFAOYSA-N 0.000 description 1
- QEYONPKSDTUPAX-UHFFFAOYSA-N 4-bromo-2-chloro-6-fluorophenol Chemical compound OC1=C(F)C=C(Br)C=C1Cl QEYONPKSDTUPAX-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001517310 Eria Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 229910017974 NH40H Inorganic materials 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000029586 bacterial cell surface binding Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011554 ferrofluid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000004186 food analysis Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- DCUFMVPCXCSVNP-UHFFFAOYSA-N methacrylic anhydride Chemical compound CC(=C)C(=O)OC(=O)C(C)=C DCUFMVPCXCSVNP-UHFFFAOYSA-N 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 229920005548 perfluoropolymer Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- TUFFYSFVSYUHPA-UHFFFAOYSA-M rhodamine 123 Chemical compound [Cl-].COC(=O)C1=CC=CC=C1C1=C(C=CC(N)=C2)C2=[O+]C2=C1C=CC(N)=C2 TUFFYSFVSYUHPA-UHFFFAOYSA-M 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
- B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3244—Non-macromolecular compounds
- B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
- B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
- B01J20/3251—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising at least two different types of heteroatoms selected from nitrogen, oxygen or sulphur
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3285—Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Specific binding materials are provided that are adapted to specifically bind with a target material characterised in that the specific binding material has areas upon its surface corresponding to the size and/or shape of the target material. Preferably the target material is a biological target material; e.g., a microorganism, antibody or antigen. Preferably the specific binding material comprises a polymeric body on which areas corresponding in size and/or shape to the target have been formed.
Description
W 096/26440 PCT/GB96/~0410 SPF.CIFIC ~INDING ~TERT~
The present inven~ion relates to specific binding materials, to methods for their preparation and methods for their use.
Particularly there are provided novel specific binding materials and methods that have application in separation and/or concentration of biological targets such as macromolecules and microorganisms. and particularly those targets found in water supplies, food and food derived materials.
It is known to immobilise biological targets, such as DNA, RNA, viruses and viral components, bacteria, antigens and antibodies, using specific binding materials. These materials typically comprise immobilised complementary species such as oligonucleotides, antibodies or antigens which have the capability to specifically bind the target. Commonly the species are immobilised on materials such as microtitre plates or wells, on latex or polymer beads or strips, on column materials such as polysaccharides, or on dipstick structures.
While the binding between these materials and their agents is primarily through charge interaction and hydrogen bonding with binding species, its efficacy is necessarily limited by the concentration o~ the binding species immobilised on the material surface. Thus the material will commonly require a high concentration of the species in order to ensure efficient capture of target from a liquid phase sample.
The present inventors have now provided novel specific binding materials that utilise target shape and/or size, as well as optionally using specific binding species, to enable capture a biological target from a liquid medium in specific fashion.
In a first aspect of the present invention there is provided a - specific binding material adapted to specifically bind with a targetmaterial characterised in that the specific binding material has areas upon its surface corresponding to the size and/or shape of the target.
Preferably the target is a biological target, eg. a microorganism such as a virus particle, bacteria. yeast, antibody or antigen, and the areas on the binding material surface are shaped and sized to accommodate a substantial part of the target material. It will be understood that by size and shape it is intended to refer to more than just a molecular level interaction such as that between two molecules; a physical size and shape of a substantial part of the target being what is being accommodated by the binding material.
Preferably the material comprises a polymeric body on which areas corresponding in size and/or shape to the target have been formed.
These areas preferably have a high affinity for binding the target;
for example the size and/or shape specific area of the material may have functionalised species such as charge bearing groups or have antibodies or antigens bound to it, eg. by covalent bonding.
In a particularly preferred aspect the present inventors have found that the specificity and affinity of the specific binding material for the target material may be increased by treating the areas of the specific binding material surface that are not sized or shaped to correspond to the target material such as to reduce their ability to bind the target or any other material from a sample from which it is being specifically selected. In this fashion the specificity of the binding is increased as only targets having the correct size or shape can be effectively bound.
Such treated or 'poisoned' specific binding materials may be used to bind any desired entity; whether a particulate material such as a virus, bacteria or other microorganism, or a specific macromolecule or smaller chemical entity. Generally such treatments are those which remove or mask the species on the binding materials surface that cause the target and other materials to become bound. Thus hydroxy groups may be esterified or converted to ethers. while carboxyl groups could be esterified or reduced. Still more effectively these groups can be masked by treatment with groups such CA 022lll74 l997-07-22 W 096126440 PCT~GB96/004I0 as silyl or perfluoro groups using entities as will be illustrated in the Examples below.
In a second aspect of the present invention there is provided a method for preparation of the specific binding materials of the present invention comprising binding a target material to the surface of the specific binding material such that the surface of the specific binding material becomes adapted the size and/or shape of the target material, then removing the target material from that surface.
In each of these aspects the surface of the specific binding material is adapted such as to be capable of conforming or interacting with the shape or size of the target such that non-target materials not having the desired shape or being too large to fit into or onto the conformed area do not become bound or bind with decreased affinity.
The conformation may be with any part of the target as long as the target can access the binding area so provided. Thus conveniently the adaptation is such that an imprint of the target is made in or on the surface of the binding material which is located and configured such to allow the target to access the binding surface.
In one embodiment of the second aspect of the invention the specific binding material is adapted to the shape and size of a target by forming a body of the specific binding material in the presence of the target material. It is known to imprint polymers with templates (see Wulff (1986) 'Polymeric Reagents and Catalysis' (ACS SympSer 308) Ed W T Ford, pl86 American Chemical Society) but not with labile materials such as the preferred biological targets of the present invention.
The condition for formation of the specific binding material body, eg. polymeric bodies, in the presence of biological target materials must meet several criteria if the specificity of the interaction for living or otherwise high temperature and chemically labile materials is to be maintained. For living material the formation preferably takes place at target physiological pH and temperature. with low W 096/26440 PCT/G~96/00410 toxicity conditions, and preferably with short reaction time and appropriate functionality for the purposes of binding the target.
Furthermore, the formation must result in a mirroring of target surface features, eg. for bacteria preferably being on a O.l to 5 um scale and more preferably on a 0.5 to 2,um scale. The material produced should preferably be durable and have easy and safe h~n~l ing characteristics.
Preferably the specific binding material is functionalised at its binding surface by functional groups, eg. such as amino and/or hydroxy and/or carboxyl and/or amide groups; these allowing for direct binding and/or functionalising of the surface once formed.
It has further been found by the present inventors that commercially available polymeric beads used for immobilising antibodies, such as Dynabeads, will bind bacteria or viruses in non-specific fashion to their surfaces to various extents. Dynabeads as such are too small to be of use in binding bacteria by shape and size interaction, but can be used to bind smaller entities such as viral targets. Other larger commercial beads will of course be usable with bacteria and larger entities such as yeasts and protozoans. These commercially available beads are ideal starting materials for the surface poisoning aspect of the present invention, but other custom made materials may of course be used.
Preparation of polymer bodies at physiological/biological pH can be carried out by interfacial reactions using dispersed organic phase.
One preferred method uses radiation cross-linking of monomer components to provide polymerisation. Once formed about the target material, the latter may be removed by a variety of means, eg. by subjecting the materials to a high vortex and/or use of acids or Alk~ . In a preferred method of the invention however there is provided a method for production of preferred materials of the r invention wherein the specific binding materials of the invention are preformed in the absence of target material; the preformed material exposed to target material, particularly in the absence of non-target materials, to allow surface interaction, ie. binding; the two W O 96/26440 PCT~GB96/00410 materials in bound form exposed to a further treatment whereby the surface of the specific binding material which is not covered by target material becomes wholly or partially inactivated with respect . to its ability to bind target and non-target materials.
~ The form of the specific binding material is not limited to any specific type; convenient forms will include beads, capsules, strips, films and membranes, ie. semi-permeable films through which samples may be passed while ret~inin~ particulates.
The materials, methods and uses of the present invention will now be described by way of illustration only by reference to the following non-limiting Examples and Figures. Further embodiments falling within the scope of the invention will occur to those skilled in the art in the light of these.
FIGURES
Figure 1: Shows a diagrammatic representation of the formation of a specific binding material body at the interface between an aqueous layer and an organic layer at which a bacteria is located.
Figure 2: Shows a diagrammatic representation of the four stages of formation areas of size and shape specific to target bacteria on polymeric beads as they form at a liquid interface.
Figure 3: Shows a diagrammatic representation of a variation of the method shown in Figure 2 wherein the beads formed from the second step, or preformed solid beads that have had bacteria bound to them, are treated such as to 'poison' unbound surfaces such as to reduce or destroy their ability to bind the target and other materials.
Figure 4:
Plates la, lb: Confocal Laser Scanning Micrographs (Zeiss LSM lD), of ethidium bromide-stained Listeria monocytogenes, and Sta~hvlococcuc aureus, respectively, attached to polyamide CA 022lll74 l997-07-22 microcapsules. Plate la depicts the upper surface of a mircocapsule with Listeria monocytogenes showing clearly in fluorescence, indicating the density of cell coverage. Plat lb is an optical slice through the middle of a polymer microcapsule: the fluorescent StAnhvlococcll~ aureu~ cells delineate the outer surface of the polymer membrane.
Plates 2a, 2b: Scanning Electron Micrographs (Hitachi S570) showing polymer beads after cross-l inking of the diacrylate-contAining organic core. The microorganisms can be seen partially embedded in the surface. The retention of the rod and coccoid shapes indicates that the gross physical morphology of the cells was unaffected by the polymerization process.
Plates 3a, 3b: Scanning Electron Micrographs depicting the "lithographic prints" of the respective bacteria. The size and shape of the "prints" can be seen to correspond exactly to those of the microorganisms. In addition to the shape anisotropy, these sites were rendered distinct chemically by reaction of the beads with a diisocyanato-tipped perfluoropolyether, thus blocking the areas of the polymer surface not covered by the microorganisms. Following the hydrolysis step to remove the cells, the original functionality at the sites was exposed, allowing for further derivitization ("development" of the lithographic prints).
Plates 4a, 4b show the "chemically-amplified" prints of the bacteria;
After removal of the bacteria, the beads were reached with a fluorescent-labelled lectin, FITC-Concanavalin A. Confocal Laser ScAnning Microscopy has been used to define an optical section across the upper surface of the polymer beads, with the bright regions corresponding to areas reactive towards FITC-Concanavalin A. The anisotropic functionality of the surfaces can be seen to match exactly the dimensions of the bacteria in Plates l and 2, and the sites in Plate 3, thus establishing the lithographic prints of the bacteria both topologically and chemically.
EXAMPLES
CA 022lll74 l997-07-22 W 0 96l26440 PCT/GB96/00410 Purification of Re~gents. The following reagents were purchased from Aldrich or Sigma and used as received: Polyallylamine (PAA) of 100,000 and Mw 14,000; (3-[N] -morpholino)propylsulphonic acid (MOPS), dibutyl ether (DBE), lysozyme (chicken egg white), l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC);
l,l'-azobis(cycloh~x~necarbonitrile) (ACCN) FOMBLIN DISOC
(perfluoropolyether, diisocyanato terminated), fluoroscein isothiocyanate (FITC), acridine orange, rhodamine 123 and sulforhodamine 101 acid chloride. 1,6-hexanedioldiacrylate (Aldrich) and divinylbenzene (80% tech. grade, Aldrich) were washed with dilute aqueous NaHC03, passed through activated neutral alumina and stored over dried 4A molecular sieves. Adipoyl chloride (Aldrich) was double -distilled in vacuo and stored under nitrogen in a Schlenk flask. Azobis(isobutyronitrile) (AIBN) was purchased from Fluka and recrystallised from methanol before use. 6-Amin~h~xylmethacrylamide was prepared by reaction of methacrylic anhydride (1.0 equivalent) with 1,6-diaminohexane under Schotten-Baumann conditions followed by repeated extraction from chloroform with dilute aqueous acid.
Growth of mi croorg~nism~. Broth cultures obtained by overnight growth at 37~C in tubes containing 9ml of yeast-dextrose broth (YDB);
contAining 10 g/l peptone; 8 g/l beef extract; 5 g/l NaCl; glucose 5 g/l; yeast extract 3 g/l; pH6.8 for cultures of StAphylococcll~
aureus NCDO 949 and S~lronella enteritidis 010 37782. Nutrient broth (NB, Unipath) for F~cherichia coli 4824/79 and coryneform broth (CB;
cont~inin~ 10 g/l tryptone; yeast extract 5 g/l, NaCl 5 g/l;
glucose 5 g/l; pH7.2) for Listeria monocvtogenes C200 type 2 and Tisteria ivAnovi C659.
F~x~mnle 1: Pre~Aration of Dolvamide-surf~ce beA~ (Polvamide 1). A
solution of MOPS buffer (o.6N. pH7.8, 250ml) was placed in a reaction ~ vessel equipped with a magnetic bar and stirred at setting 5 over aIKA-MINI-MR stirrer plate whilst nitrogen was bubbled through for 10 minutes. A solution of adipoyl chloride (1.2 ml) in a mixed organic phase containing dibutyl ether (14.4 ml), 1.6-hexanedioldiacrylate (14.4 ml) and AIBN (300mg) was added and the stirrer speed was CA 022lll74 l997-07-22 increased to setting 6 for 5 minutes before dropwise addition of polyallylamine solution (Mw 100,000, 0.2N in o.6N MOPS, 45ml) with MOPS (30ml of 0,6N). The capsules formed were irradiated (Blak-Ray B-lOOA lamp) with stirring for 12hrs and the resultant polymer beads filtered, washed with water (3 x lOOml) and methanol (3 x lOOml) and dried in air. O
Fx~mDle 2: Prep~ration of ~olv~mide surface be~ with optimised DhvsicAl DroDerties (PolyAmide 2~. A solution of sodium carbonate buffer (0.5N, pH11.5, 400ml) was placed in a reaction vessel equipped with a magnetic bar and stirred at setting 5 over a IKA-MINI-MR
stirrer plate whilst nitrogen was bubbled through for 10 minutes. A
solution of adipoyl chloride (2.0ml) in a mixed organic phase contAining chloroform (25ml), divinylbenzene (25ml), and ACCN (300mg) was added and the stirrer speed was increased to setting 6 for 5 minutes before dropwise addition of polyallylamine solution (Mw 100,000, 0.2N in 0.5N Na2CO3, 50ml). The capsules formed were irradiated (Blak-Ray B-lOOA lamp) with stirring for 12 hours and the resultant polymer beads were filtered, washed with water (3 x lOOml) and methanol (3 x lOOml) and dried in air.
Fx~Dle ~: PrepAration of 'I~rinted' ~olymeric adsorbents ~I~Drinted Polvmer 1~. A solution of MOPS buffer (0.6N, pH7.8, 250ml) was placed in a reaction vessel equipped with a magnetic stirrer bar and stirred at setting 5 over a IKA-MINI-MR stirrer plate whilst nitrogen was bubbled through for 10 minutes. A solution of adipoyl chloride (1.2ml) in a mixed organic phase containing dibutyl ether (14.4ml), 1,6-hexandiol -diacrylate (14.4ml) and AIBN (300mg) was added and the stirrer speed increased to setting 6 for 2 minutes before a suspension of Listeria monocytogenes (ethidium dibromide stained, 200ml of 101~cfu. ml~l), pre-stirred for ten minutes in MOPS buffer (50ml), was added and stirring continued for 3 minutes before dropwise addition of polyallylamine solution (Mw 100,000, 0.2N
in o.6N MOPS, 45ml) with MOPS (30ml of 0.6N). The capsules formed were assessed for bacterial binding by Confocal Laser ScAnni ng Microscopy (CLSM) and irradiated (Blak-Ray B-lOOA lamp) with stirring for 12 hours. The resultant polymer beads were filtered, washed with CA 022lll74 l997-07-22 _g_ water (3 x lOOml) and methanol (3 x lOOml) and dried in air.
E~m~le 4: PreDaration of 'Imrrinted' polymeric adsorbents rinted Polymer 7). A suspension of Jisteri~ ~onocytogenes (5.0ml of 101~cfu/ml) was stirred in MOPS buffer (o.6N, lOOml) as nitrogen was bubbled through for 10 minutes. Stirring speed was increased to setting 6 (IKA-MINI-MR) as a solution of AIBN (lOOmg), 6-l ;nohexylmethacrylate (l.Og) in chloroform/1,6-hexanedioldiacrylate (50:50 v/v, lOml) was added.
Stirring was continued under UV irradiation for 5 minutes at setting 4 (IKA-MINI-MR) and then at setting 1 until bead solidification occurred. The resultant beads were washed with methanol (5 x lOOml)and air dried.
Metho~ for re~ovin~ bacteria from beA~ of Fx~nles 1 to 4:
Physical Shear method for detaching bacteria: this was carried out in flat-bottomed glass universals using a bench whirlimixer. DEFT
counts were performed on bacteria released from samples of imprinted beads after vortexing. Beads were examined by DEFT and confocal microscopy to confirm removal.
Chemic~l ~etho~ for detachin~ bacteri~ from ~olymer surfaces:
Solutions of NaCl (l.OM), Urea (8.oM), citrate and borate buffers (l.OM, varying pH) were prepared in deionized water and sterilized by autoclaving. Phosphate buffer (l.OM, varying pH) was filter sterilised. Imprinted beads were resuspended in solutions of varying pH (2.0-11.0), concentration of phosphate (O-l.OM), NaCl (O-l.OM) and urea (o-8.oM). Liberated bacteria were detected by DEFT. Samples of beads were boiled in 2.OM HCl or 2.OM NH40H for 2 hours prior to DEFT
analysis.
Exam~le ~: Pre~aration of 'Im~rinted' ~olvmeric adsorbents Im~rinted Polymer Film ~). A suspension of Listeria ~onocyto~enes (5.0ml of 108cfu/ml) was stirred in MOPS buffer (o.6N, lOOml) as nitrogen was bubbled through for 10 minutes. The suspension was then poured carefully onto a solution of AIBN (lOOmg), 6-~ino~exylmethacrylate (l.Og) in chloroform/1.6-hexandioldiacrylate CA 022lll74 l997-07-22 (50:50 v/v, lOml) in a beaker. Irradiation of the two-phase system was carried out until film solidification occurred. The resultant film was washed with methanol prior to examination by ScAnn;n~
Electron Microscopy. Samples were then washed with either 6M r HCl/MeOH or 50% ~ --iA 880/MeOH solution to remove bacteria.
FxArnle 6 PreDArAtion of ;mnrinted ~olvmer beA~ with 'poisoned' surface. (Imrrinted Polymer 4). A suspension of imprinted polymer beads (l.Og) was stirred in 1,1,2 -trichlorotrifluoroethane (250ml) was stirred rapidly as a solution of FOMBLIN DISOC (1.5g perfluoropolyether, diisocyanato terminated) in 1,1,2-trifluorotrichloroethane (20ml) was added dropwise via a funnel equipped with a drying tube. Stirring was continued for 3 hours before addition of the suspension to methanol (250ml) and the solvent was removed by decanting before washing the beads with further methanol (5 x lOOml).
FxAmnle 7 R~mnvAl of bacteria from 'Im~rinted' ~olymer bea~.
(Imnrinted ~olymer ~). A suspension of imprinted polymer beads (250mg) was refluxed in 6M HCl/methanol (150ml) for 36 hours with regular monitoring of the extent of cell removal by Scanning Electron Microscope. The beads were then repeatedly washed in methanol and dried in air.
F~xAmDle 8: PreDaration of 'Foot~rinted' ~olymer beads havin~ size And sha~e adAntation 'on' bead surface. Preformed polymer polyamide beads (l.Og) were added to 50ml of 1/4 strength Ringer's solution in the presence of bacteria serially diluted in 0.1% peptone to give a final concentration of 108 cfu/ml. The beads were incubated for 2 hours at 4~C with rolling.
F~-AmDle 9: Pre~aration of 'FootDrinted' beads with 'poisoned' v surfAce (FootDrinted Polymer 1). Polymer beads with adsorbed bacteria (l.Og) were stirred in 1,1,2-trichlorofluoroethane (250ml) was stirred rapidly as a solution of FOMBLIN DISOC (1.5g perfluorpolyether, diidocyanato terminated) in 1,1,2-trichloroethane (20ml) was added dropwise via a funnel equipped with a drying tube.
CA 022lll74 l997-07-22 W 096l26440 PCT/GB96~00410 Stirring was continued for 3 hours before addition of the suspension to methanol (250ml), the solvent was removed by decanting and the beads were washed with further methanol (5 x lOOml).
ple 10: Remov~l of bac~eria from 'Foot~rinted' be~ wit~
'Doison~d' surf~e (Foot~rinted Dolymer 2). A suspension of imprinted polymer beads (250mg) was refluxed in lM HCl /methanol (150ml) for 4 hours with regular monitoring of the extent of cell removal by Scanning Electron Microscopy. The beads were then repeatedly washed in methanol and dried in air.
Fx~nle 11: Use of S~ecific binding ~teri~l beads of the invention.
Specificity of beads of the invention was determined (see Table 1).
Plate collnt: Serial dilutions of F~cherichia coli. St~rhylococcus aurel~, Listeri~ monocvtogenes and Salmonella enteritidis in 0.1%
peptone were plated using Yeast-Dextrose Agar (Unipath Ltd.
Basingstoke UK) Colonies were counted after 24 to 48 hours incubation at 30~C.
Direct ~nifluorescent Terhni aue (D~FT) Bac~eri~l Collnt: The DEFT was performed according to British Standard Methods BS 4285. The pre-filtration step using 5.0 micron nylon mesh to remove particulate matter from suspension was ommitted.
Confoc~l Examination of S~mnles: Samples of imprinted beads were dual stained in ethidium bromide and acridine orange, prior to examination by confocal microscopy. Samples were initially stained for 2 minutes by immersion in 0.1% ethidium bromide prepared in 0.05%
benzalkonium chloride and were rinsed three times with deionised water before staining in acridine orange (0.025% in O.lM citrate/NaOH
buffer, pH6.6). After 2 minutes samples were washed twice in O.lM
citrate/NaOH at pH3Ø Stained preparations were mounted onto a microscope slide and covered with a coverslip. Microscopic ~xr in~tion was made using a Zeiss confocal laser scanning microscope (LSM lD), operating at an excitation wavelength of 488nm using an Argon ion laser. Images of 512 x 512 pixels were photographed directly from a high resolution videophotometer using a Nikon F301 camera.
TABLE l: Bacterial Adsorption by Beads of the Examples.
~.
Polymer Bacterial species Conc. Bacteria%Bacteria added added cfu/assay extracted Polyamide l Listeria 104 52 Non-imprinted monocytogenes Polyamide l S~l monell a 104 20 Imprinted enteritidis Footprinted Listeria lO'' 9 polymer l monocytogenes 'poisoned' Footprinted Salmonella 104 o polymer l enteritidis 'poisoned' Listeria Listeria 104 48 Footprinted monocytogenes Polymer 2 Listeria Salmonella 104 13 Footprinted enteritidis Polymer 2 Salmonella Listeria 104 10 Footprinted monocytogenes Polymer 2 Salmonella Salmonella 104 21 Footprinted enteritidis Polymer 2 CA 02211174 l997-07-22 WO 96/26440 I?CT~GB96~00~10 Samples contained 5ml buffer (lOmM MOPS pH7.0), 50mg polymer beads, lOOml bacteria (104 cfu/ml). Rotation was carried out for 2 hours followed by settling of beads. Samples of supernatant (lOOml) were drawn and plated for bacterial counting.
In order to demonstrate the increase in specific binding provided by these treatments over the non-specific binding provided using commercially available untreated beads, a comparative test was carried out using Dynabeads available from Dynal A/S PO Box 158.
Skoyen, N0212 Oslo, Norway that had Salronell~ antibodies immobilised upon them.
TABLE 2: Bacterial ~xtraction using antibodies on Dynabeads.
Bacterial speciesConc. added cfu/ml %Extracted S. typhimurium 105 24 E. coli 104 13 S. enteritidis 103 20 L. monocytogenes 104 28 ~ Assays were carried out in accordance with the manufacturers instructions.
CA 022lll74 l997-07-22 E~mele 1~: Attachm~nt of enzymes to Doly~m;nes.
The method of forming a specific binding material shown diagrammatically in Figure 1 and Figure 2 wherein ligand L is lysozyme was carried out by dissolving lysozyme (14.4mg, O.OOlmmol) and polyallylamine.HCl (~ 14,000) (lOOmg-lmmol) in MOPS buffer (50mM, 5ml) and adjusting the pH of the solution to 4.5. A solution of EDC (19.2mg, O.lmmol) in water (lml) was added and the reaction vessel was stirred gently at room temperature overnight with maintenance at pH4.5 throughout. The solution was then dialysed against MOPS buffer (30mM pH6.8, 3 x lOOml) before concentration (Amicon PM10 membrane) and purification by gel filtration (Sephacryl 200; elution with 30mM MOPS, lOOmM KCl, lmM EDTA, pH6.8). Fractions exhibiting UV absorption at 280nm were combined, concentrated (Amicon PM3 membrane) and lyophilised to leave a white powdery solid (50mg).
This material can be used to form the beads of the invention by substitution for the polyallylamine reactants in each case.
Fx~r~le 1~: visualisation of ~rocess with SEM
A solution of 3-[N]-morpholino/propylsulphonic acid (MOPS) buffer (pH
7.8, 0.6N, 250ml) was purged with nitrogen for 10 minutes before addition of adipoyl chloride (1.2ml) in a mixed organic phase contAining dibutyl ether (14.4ml), 1,6-hexanedioldiacrylate (14.4ml), and azobis (isobutyronitrile) (300mg). A suspension of bacteria (T.i~teria ronocytogenes or St~ehylococcus auren~, ethidium bromide stained, 4 x 108cfu.ml~l), in MOPS buffer (50ml), was then added and stirring continued for 3 minutes before dropwise addition of poly(allylamine) solution (0.12N in 0.6N MOPS, pH 7.8, 75ml). The resultant microcapsules with attached bacteria were irradiated (360nm) with stirring for 12 hours to generate solid beads which were filtered, washed and water (3 x lOOml), methanol (3 x lOOml) and air-dried. The beads (5.0g) were then stirred in 1,1,2-trichlorotrifluoroethane (250ml) as a solution of diisocyanato-terminated perfluoropolyether (FOMBLIN Z DISOC 1.5g) in CA 022lll74 l997-07-22 1,1,2-trifluorotrichloroehane (20ml) was added dropwise. Stirring was continued for 3 hours before the reaction was terminated by addition of suspension to methanol (250 ml). After filtration and methanol washing (5 x lOOmL), the beads were refluxed in 6M
HCl/methanol (150ml) to remove the bacteria. "Development" of the exposed lithographic prints was effected by stirring the beads (lOOmg) in pH 4.75 sodium acetate buffer (5ml, 50mM, cont~ining 5mM
MnCl2, 5mM CaCl2, and ethanol (500ml)) with fluorescein isothiocyanate-labelled Concanavalin A (lmg, ~ O.OOOlmmol) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (5mg, 0.025mmol).
At each stage of the procedure the appearance and morphology of the polymers was monitored using a combination of Confocal Laser Scanning Microscopy (CLSM) and Scanning Electron Microscopy (SEM) (Figure 4).
Plate la and lb show the initial polyamide microcapsules, cont~inin~
a liquid organic core, with surface-bound Listeri~ monocyto~enes and StAnhylococclls aurell~ as representative rod-shaped and coccoidal bacteria respectively. The cells were labelled with the fluorescent dye ethidium bromide for this experiment. It is evident from the optical slices shown that the microorganisms were located on the outside of the polymer capsules, and the degree of surface coverage was easily controlled by variation of initial microorganism concentration and polymerization conditions. Photomicrographs of polymeric beads obtained after irradiation of the respective capsules are presented in Plates 2a and 2b. Examination of the surface by SEM
showed a certain degree of variation with regard to position of the bacteria at the surface, with some cells almost completely buried in the outer layer of the polyamide and the majority only slightly embedded in the surface. After removal of the template microorganisms, the presence of deep indentations (100-200nm) was readily apparent in SEM micrographs (Plates 3a and 3b). These "sites" exhibited exact size and shape complementarity to the ~ bacteria. However, to demonstrate the success of our lithographic procedure it was necessary to "develop" the difference in chemical functionality between the now exposed sites and the perfluoropolymer modified surfaces. The beads were therefore reacted with a fluorescent labelled lectin (FITC-Concanavalin A) via l-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) mediated coupling of free amino groups on the unmodified polymer surfaces with carboxyl residues on the lectin. This enabled us to achieve a chemical amplification of the site functionality, visualised by CLSM, but exactly the same procedure can be used for the introduction of a specific ligand (antibodies or lectins) for selective recognition of the template microorganism. The results of this experiment are shown in Plates 4a and 4b where the lithographic image of the cells on the polymeric surface is ~nh~nced and developed through the use of the fluorescent dye.
This experiment clearly shows that it is possible to recreate the shape and size of whole cells employed as templates during multi-component polymer synthesis. The resultant polymeric beads exhibiting functionally anisotroPiC patches, of dimensions defined by the template, can be further modified to adjust the chemistry in the sites and/or to introduce any further recognition elements required for a particular use. The materials obtained are expected to find wide ranging applications in the biomedical field and environmental/food analysis where the rapid, efficient separation and recovery of cells, microorganisms and viruses is of paramount importance. Incorporation of, for example, ferrofluids in the organic core of these polymer particles will enable the exploitation of these materials in diagnostic applications where magnetic separations are already in widespread use.
-
The present inven~ion relates to specific binding materials, to methods for their preparation and methods for their use.
Particularly there are provided novel specific binding materials and methods that have application in separation and/or concentration of biological targets such as macromolecules and microorganisms. and particularly those targets found in water supplies, food and food derived materials.
It is known to immobilise biological targets, such as DNA, RNA, viruses and viral components, bacteria, antigens and antibodies, using specific binding materials. These materials typically comprise immobilised complementary species such as oligonucleotides, antibodies or antigens which have the capability to specifically bind the target. Commonly the species are immobilised on materials such as microtitre plates or wells, on latex or polymer beads or strips, on column materials such as polysaccharides, or on dipstick structures.
While the binding between these materials and their agents is primarily through charge interaction and hydrogen bonding with binding species, its efficacy is necessarily limited by the concentration o~ the binding species immobilised on the material surface. Thus the material will commonly require a high concentration of the species in order to ensure efficient capture of target from a liquid phase sample.
The present inventors have now provided novel specific binding materials that utilise target shape and/or size, as well as optionally using specific binding species, to enable capture a biological target from a liquid medium in specific fashion.
In a first aspect of the present invention there is provided a - specific binding material adapted to specifically bind with a targetmaterial characterised in that the specific binding material has areas upon its surface corresponding to the size and/or shape of the target.
Preferably the target is a biological target, eg. a microorganism such as a virus particle, bacteria. yeast, antibody or antigen, and the areas on the binding material surface are shaped and sized to accommodate a substantial part of the target material. It will be understood that by size and shape it is intended to refer to more than just a molecular level interaction such as that between two molecules; a physical size and shape of a substantial part of the target being what is being accommodated by the binding material.
Preferably the material comprises a polymeric body on which areas corresponding in size and/or shape to the target have been formed.
These areas preferably have a high affinity for binding the target;
for example the size and/or shape specific area of the material may have functionalised species such as charge bearing groups or have antibodies or antigens bound to it, eg. by covalent bonding.
In a particularly preferred aspect the present inventors have found that the specificity and affinity of the specific binding material for the target material may be increased by treating the areas of the specific binding material surface that are not sized or shaped to correspond to the target material such as to reduce their ability to bind the target or any other material from a sample from which it is being specifically selected. In this fashion the specificity of the binding is increased as only targets having the correct size or shape can be effectively bound.
Such treated or 'poisoned' specific binding materials may be used to bind any desired entity; whether a particulate material such as a virus, bacteria or other microorganism, or a specific macromolecule or smaller chemical entity. Generally such treatments are those which remove or mask the species on the binding materials surface that cause the target and other materials to become bound. Thus hydroxy groups may be esterified or converted to ethers. while carboxyl groups could be esterified or reduced. Still more effectively these groups can be masked by treatment with groups such CA 022lll74 l997-07-22 W 096126440 PCT~GB96/004I0 as silyl or perfluoro groups using entities as will be illustrated in the Examples below.
In a second aspect of the present invention there is provided a method for preparation of the specific binding materials of the present invention comprising binding a target material to the surface of the specific binding material such that the surface of the specific binding material becomes adapted the size and/or shape of the target material, then removing the target material from that surface.
In each of these aspects the surface of the specific binding material is adapted such as to be capable of conforming or interacting with the shape or size of the target such that non-target materials not having the desired shape or being too large to fit into or onto the conformed area do not become bound or bind with decreased affinity.
The conformation may be with any part of the target as long as the target can access the binding area so provided. Thus conveniently the adaptation is such that an imprint of the target is made in or on the surface of the binding material which is located and configured such to allow the target to access the binding surface.
In one embodiment of the second aspect of the invention the specific binding material is adapted to the shape and size of a target by forming a body of the specific binding material in the presence of the target material. It is known to imprint polymers with templates (see Wulff (1986) 'Polymeric Reagents and Catalysis' (ACS SympSer 308) Ed W T Ford, pl86 American Chemical Society) but not with labile materials such as the preferred biological targets of the present invention.
The condition for formation of the specific binding material body, eg. polymeric bodies, in the presence of biological target materials must meet several criteria if the specificity of the interaction for living or otherwise high temperature and chemically labile materials is to be maintained. For living material the formation preferably takes place at target physiological pH and temperature. with low W 096/26440 PCT/G~96/00410 toxicity conditions, and preferably with short reaction time and appropriate functionality for the purposes of binding the target.
Furthermore, the formation must result in a mirroring of target surface features, eg. for bacteria preferably being on a O.l to 5 um scale and more preferably on a 0.5 to 2,um scale. The material produced should preferably be durable and have easy and safe h~n~l ing characteristics.
Preferably the specific binding material is functionalised at its binding surface by functional groups, eg. such as amino and/or hydroxy and/or carboxyl and/or amide groups; these allowing for direct binding and/or functionalising of the surface once formed.
It has further been found by the present inventors that commercially available polymeric beads used for immobilising antibodies, such as Dynabeads, will bind bacteria or viruses in non-specific fashion to their surfaces to various extents. Dynabeads as such are too small to be of use in binding bacteria by shape and size interaction, but can be used to bind smaller entities such as viral targets. Other larger commercial beads will of course be usable with bacteria and larger entities such as yeasts and protozoans. These commercially available beads are ideal starting materials for the surface poisoning aspect of the present invention, but other custom made materials may of course be used.
Preparation of polymer bodies at physiological/biological pH can be carried out by interfacial reactions using dispersed organic phase.
One preferred method uses radiation cross-linking of monomer components to provide polymerisation. Once formed about the target material, the latter may be removed by a variety of means, eg. by subjecting the materials to a high vortex and/or use of acids or Alk~ . In a preferred method of the invention however there is provided a method for production of preferred materials of the r invention wherein the specific binding materials of the invention are preformed in the absence of target material; the preformed material exposed to target material, particularly in the absence of non-target materials, to allow surface interaction, ie. binding; the two W O 96/26440 PCT~GB96/00410 materials in bound form exposed to a further treatment whereby the surface of the specific binding material which is not covered by target material becomes wholly or partially inactivated with respect . to its ability to bind target and non-target materials.
~ The form of the specific binding material is not limited to any specific type; convenient forms will include beads, capsules, strips, films and membranes, ie. semi-permeable films through which samples may be passed while ret~inin~ particulates.
The materials, methods and uses of the present invention will now be described by way of illustration only by reference to the following non-limiting Examples and Figures. Further embodiments falling within the scope of the invention will occur to those skilled in the art in the light of these.
FIGURES
Figure 1: Shows a diagrammatic representation of the formation of a specific binding material body at the interface between an aqueous layer and an organic layer at which a bacteria is located.
Figure 2: Shows a diagrammatic representation of the four stages of formation areas of size and shape specific to target bacteria on polymeric beads as they form at a liquid interface.
Figure 3: Shows a diagrammatic representation of a variation of the method shown in Figure 2 wherein the beads formed from the second step, or preformed solid beads that have had bacteria bound to them, are treated such as to 'poison' unbound surfaces such as to reduce or destroy their ability to bind the target and other materials.
Figure 4:
Plates la, lb: Confocal Laser Scanning Micrographs (Zeiss LSM lD), of ethidium bromide-stained Listeria monocytogenes, and Sta~hvlococcuc aureus, respectively, attached to polyamide CA 022lll74 l997-07-22 microcapsules. Plate la depicts the upper surface of a mircocapsule with Listeria monocytogenes showing clearly in fluorescence, indicating the density of cell coverage. Plat lb is an optical slice through the middle of a polymer microcapsule: the fluorescent StAnhvlococcll~ aureu~ cells delineate the outer surface of the polymer membrane.
Plates 2a, 2b: Scanning Electron Micrographs (Hitachi S570) showing polymer beads after cross-l inking of the diacrylate-contAining organic core. The microorganisms can be seen partially embedded in the surface. The retention of the rod and coccoid shapes indicates that the gross physical morphology of the cells was unaffected by the polymerization process.
Plates 3a, 3b: Scanning Electron Micrographs depicting the "lithographic prints" of the respective bacteria. The size and shape of the "prints" can be seen to correspond exactly to those of the microorganisms. In addition to the shape anisotropy, these sites were rendered distinct chemically by reaction of the beads with a diisocyanato-tipped perfluoropolyether, thus blocking the areas of the polymer surface not covered by the microorganisms. Following the hydrolysis step to remove the cells, the original functionality at the sites was exposed, allowing for further derivitization ("development" of the lithographic prints).
Plates 4a, 4b show the "chemically-amplified" prints of the bacteria;
After removal of the bacteria, the beads were reached with a fluorescent-labelled lectin, FITC-Concanavalin A. Confocal Laser ScAnning Microscopy has been used to define an optical section across the upper surface of the polymer beads, with the bright regions corresponding to areas reactive towards FITC-Concanavalin A. The anisotropic functionality of the surfaces can be seen to match exactly the dimensions of the bacteria in Plates l and 2, and the sites in Plate 3, thus establishing the lithographic prints of the bacteria both topologically and chemically.
EXAMPLES
CA 022lll74 l997-07-22 W 0 96l26440 PCT/GB96/00410 Purification of Re~gents. The following reagents were purchased from Aldrich or Sigma and used as received: Polyallylamine (PAA) of 100,000 and Mw 14,000; (3-[N] -morpholino)propylsulphonic acid (MOPS), dibutyl ether (DBE), lysozyme (chicken egg white), l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC);
l,l'-azobis(cycloh~x~necarbonitrile) (ACCN) FOMBLIN DISOC
(perfluoropolyether, diisocyanato terminated), fluoroscein isothiocyanate (FITC), acridine orange, rhodamine 123 and sulforhodamine 101 acid chloride. 1,6-hexanedioldiacrylate (Aldrich) and divinylbenzene (80% tech. grade, Aldrich) were washed with dilute aqueous NaHC03, passed through activated neutral alumina and stored over dried 4A molecular sieves. Adipoyl chloride (Aldrich) was double -distilled in vacuo and stored under nitrogen in a Schlenk flask. Azobis(isobutyronitrile) (AIBN) was purchased from Fluka and recrystallised from methanol before use. 6-Amin~h~xylmethacrylamide was prepared by reaction of methacrylic anhydride (1.0 equivalent) with 1,6-diaminohexane under Schotten-Baumann conditions followed by repeated extraction from chloroform with dilute aqueous acid.
Growth of mi croorg~nism~. Broth cultures obtained by overnight growth at 37~C in tubes containing 9ml of yeast-dextrose broth (YDB);
contAining 10 g/l peptone; 8 g/l beef extract; 5 g/l NaCl; glucose 5 g/l; yeast extract 3 g/l; pH6.8 for cultures of StAphylococcll~
aureus NCDO 949 and S~lronella enteritidis 010 37782. Nutrient broth (NB, Unipath) for F~cherichia coli 4824/79 and coryneform broth (CB;
cont~inin~ 10 g/l tryptone; yeast extract 5 g/l, NaCl 5 g/l;
glucose 5 g/l; pH7.2) for Listeria monocvtogenes C200 type 2 and Tisteria ivAnovi C659.
F~x~mnle 1: Pre~Aration of Dolvamide-surf~ce beA~ (Polvamide 1). A
solution of MOPS buffer (o.6N. pH7.8, 250ml) was placed in a reaction ~ vessel equipped with a magnetic bar and stirred at setting 5 over aIKA-MINI-MR stirrer plate whilst nitrogen was bubbled through for 10 minutes. A solution of adipoyl chloride (1.2 ml) in a mixed organic phase containing dibutyl ether (14.4 ml), 1.6-hexanedioldiacrylate (14.4 ml) and AIBN (300mg) was added and the stirrer speed was CA 022lll74 l997-07-22 increased to setting 6 for 5 minutes before dropwise addition of polyallylamine solution (Mw 100,000, 0.2N in o.6N MOPS, 45ml) with MOPS (30ml of 0,6N). The capsules formed were irradiated (Blak-Ray B-lOOA lamp) with stirring for 12hrs and the resultant polymer beads filtered, washed with water (3 x lOOml) and methanol (3 x lOOml) and dried in air. O
Fx~mDle 2: Prep~ration of ~olv~mide surface be~ with optimised DhvsicAl DroDerties (PolyAmide 2~. A solution of sodium carbonate buffer (0.5N, pH11.5, 400ml) was placed in a reaction vessel equipped with a magnetic bar and stirred at setting 5 over a IKA-MINI-MR
stirrer plate whilst nitrogen was bubbled through for 10 minutes. A
solution of adipoyl chloride (2.0ml) in a mixed organic phase contAining chloroform (25ml), divinylbenzene (25ml), and ACCN (300mg) was added and the stirrer speed was increased to setting 6 for 5 minutes before dropwise addition of polyallylamine solution (Mw 100,000, 0.2N in 0.5N Na2CO3, 50ml). The capsules formed were irradiated (Blak-Ray B-lOOA lamp) with stirring for 12 hours and the resultant polymer beads were filtered, washed with water (3 x lOOml) and methanol (3 x lOOml) and dried in air.
Fx~Dle ~: PrepAration of 'I~rinted' ~olymeric adsorbents ~I~Drinted Polvmer 1~. A solution of MOPS buffer (0.6N, pH7.8, 250ml) was placed in a reaction vessel equipped with a magnetic stirrer bar and stirred at setting 5 over a IKA-MINI-MR stirrer plate whilst nitrogen was bubbled through for 10 minutes. A solution of adipoyl chloride (1.2ml) in a mixed organic phase containing dibutyl ether (14.4ml), 1,6-hexandiol -diacrylate (14.4ml) and AIBN (300mg) was added and the stirrer speed increased to setting 6 for 2 minutes before a suspension of Listeria monocytogenes (ethidium dibromide stained, 200ml of 101~cfu. ml~l), pre-stirred for ten minutes in MOPS buffer (50ml), was added and stirring continued for 3 minutes before dropwise addition of polyallylamine solution (Mw 100,000, 0.2N
in o.6N MOPS, 45ml) with MOPS (30ml of 0.6N). The capsules formed were assessed for bacterial binding by Confocal Laser ScAnni ng Microscopy (CLSM) and irradiated (Blak-Ray B-lOOA lamp) with stirring for 12 hours. The resultant polymer beads were filtered, washed with CA 022lll74 l997-07-22 _g_ water (3 x lOOml) and methanol (3 x lOOml) and dried in air.
E~m~le 4: PreDaration of 'Imrrinted' polymeric adsorbents rinted Polymer 7). A suspension of Jisteri~ ~onocytogenes (5.0ml of 101~cfu/ml) was stirred in MOPS buffer (o.6N, lOOml) as nitrogen was bubbled through for 10 minutes. Stirring speed was increased to setting 6 (IKA-MINI-MR) as a solution of AIBN (lOOmg), 6-l ;nohexylmethacrylate (l.Og) in chloroform/1,6-hexanedioldiacrylate (50:50 v/v, lOml) was added.
Stirring was continued under UV irradiation for 5 minutes at setting 4 (IKA-MINI-MR) and then at setting 1 until bead solidification occurred. The resultant beads were washed with methanol (5 x lOOml)and air dried.
Metho~ for re~ovin~ bacteria from beA~ of Fx~nles 1 to 4:
Physical Shear method for detaching bacteria: this was carried out in flat-bottomed glass universals using a bench whirlimixer. DEFT
counts were performed on bacteria released from samples of imprinted beads after vortexing. Beads were examined by DEFT and confocal microscopy to confirm removal.
Chemic~l ~etho~ for detachin~ bacteri~ from ~olymer surfaces:
Solutions of NaCl (l.OM), Urea (8.oM), citrate and borate buffers (l.OM, varying pH) were prepared in deionized water and sterilized by autoclaving. Phosphate buffer (l.OM, varying pH) was filter sterilised. Imprinted beads were resuspended in solutions of varying pH (2.0-11.0), concentration of phosphate (O-l.OM), NaCl (O-l.OM) and urea (o-8.oM). Liberated bacteria were detected by DEFT. Samples of beads were boiled in 2.OM HCl or 2.OM NH40H for 2 hours prior to DEFT
analysis.
Exam~le ~: Pre~aration of 'Im~rinted' ~olvmeric adsorbents Im~rinted Polymer Film ~). A suspension of Listeria ~onocyto~enes (5.0ml of 108cfu/ml) was stirred in MOPS buffer (o.6N, lOOml) as nitrogen was bubbled through for 10 minutes. The suspension was then poured carefully onto a solution of AIBN (lOOmg), 6-~ino~exylmethacrylate (l.Og) in chloroform/1.6-hexandioldiacrylate CA 022lll74 l997-07-22 (50:50 v/v, lOml) in a beaker. Irradiation of the two-phase system was carried out until film solidification occurred. The resultant film was washed with methanol prior to examination by ScAnn;n~
Electron Microscopy. Samples were then washed with either 6M r HCl/MeOH or 50% ~ --iA 880/MeOH solution to remove bacteria.
FxArnle 6 PreDArAtion of ;mnrinted ~olvmer beA~ with 'poisoned' surface. (Imrrinted Polymer 4). A suspension of imprinted polymer beads (l.Og) was stirred in 1,1,2 -trichlorotrifluoroethane (250ml) was stirred rapidly as a solution of FOMBLIN DISOC (1.5g perfluoropolyether, diisocyanato terminated) in 1,1,2-trifluorotrichloroethane (20ml) was added dropwise via a funnel equipped with a drying tube. Stirring was continued for 3 hours before addition of the suspension to methanol (250ml) and the solvent was removed by decanting before washing the beads with further methanol (5 x lOOml).
FxAmnle 7 R~mnvAl of bacteria from 'Im~rinted' ~olymer bea~.
(Imnrinted ~olymer ~). A suspension of imprinted polymer beads (250mg) was refluxed in 6M HCl/methanol (150ml) for 36 hours with regular monitoring of the extent of cell removal by Scanning Electron Microscope. The beads were then repeatedly washed in methanol and dried in air.
F~xAmDle 8: PreDaration of 'Foot~rinted' ~olymer beads havin~ size And sha~e adAntation 'on' bead surface. Preformed polymer polyamide beads (l.Og) were added to 50ml of 1/4 strength Ringer's solution in the presence of bacteria serially diluted in 0.1% peptone to give a final concentration of 108 cfu/ml. The beads were incubated for 2 hours at 4~C with rolling.
F~-AmDle 9: Pre~aration of 'FootDrinted' beads with 'poisoned' v surfAce (FootDrinted Polymer 1). Polymer beads with adsorbed bacteria (l.Og) were stirred in 1,1,2-trichlorofluoroethane (250ml) was stirred rapidly as a solution of FOMBLIN DISOC (1.5g perfluorpolyether, diidocyanato terminated) in 1,1,2-trichloroethane (20ml) was added dropwise via a funnel equipped with a drying tube.
CA 022lll74 l997-07-22 W 096l26440 PCT/GB96~00410 Stirring was continued for 3 hours before addition of the suspension to methanol (250ml), the solvent was removed by decanting and the beads were washed with further methanol (5 x lOOml).
ple 10: Remov~l of bac~eria from 'Foot~rinted' be~ wit~
'Doison~d' surf~e (Foot~rinted Dolymer 2). A suspension of imprinted polymer beads (250mg) was refluxed in lM HCl /methanol (150ml) for 4 hours with regular monitoring of the extent of cell removal by Scanning Electron Microscopy. The beads were then repeatedly washed in methanol and dried in air.
Fx~nle 11: Use of S~ecific binding ~teri~l beads of the invention.
Specificity of beads of the invention was determined (see Table 1).
Plate collnt: Serial dilutions of F~cherichia coli. St~rhylococcus aurel~, Listeri~ monocvtogenes and Salmonella enteritidis in 0.1%
peptone were plated using Yeast-Dextrose Agar (Unipath Ltd.
Basingstoke UK) Colonies were counted after 24 to 48 hours incubation at 30~C.
Direct ~nifluorescent Terhni aue (D~FT) Bac~eri~l Collnt: The DEFT was performed according to British Standard Methods BS 4285. The pre-filtration step using 5.0 micron nylon mesh to remove particulate matter from suspension was ommitted.
Confoc~l Examination of S~mnles: Samples of imprinted beads were dual stained in ethidium bromide and acridine orange, prior to examination by confocal microscopy. Samples were initially stained for 2 minutes by immersion in 0.1% ethidium bromide prepared in 0.05%
benzalkonium chloride and were rinsed three times with deionised water before staining in acridine orange (0.025% in O.lM citrate/NaOH
buffer, pH6.6). After 2 minutes samples were washed twice in O.lM
citrate/NaOH at pH3Ø Stained preparations were mounted onto a microscope slide and covered with a coverslip. Microscopic ~xr in~tion was made using a Zeiss confocal laser scanning microscope (LSM lD), operating at an excitation wavelength of 488nm using an Argon ion laser. Images of 512 x 512 pixels were photographed directly from a high resolution videophotometer using a Nikon F301 camera.
TABLE l: Bacterial Adsorption by Beads of the Examples.
~.
Polymer Bacterial species Conc. Bacteria%Bacteria added added cfu/assay extracted Polyamide l Listeria 104 52 Non-imprinted monocytogenes Polyamide l S~l monell a 104 20 Imprinted enteritidis Footprinted Listeria lO'' 9 polymer l monocytogenes 'poisoned' Footprinted Salmonella 104 o polymer l enteritidis 'poisoned' Listeria Listeria 104 48 Footprinted monocytogenes Polymer 2 Listeria Salmonella 104 13 Footprinted enteritidis Polymer 2 Salmonella Listeria 104 10 Footprinted monocytogenes Polymer 2 Salmonella Salmonella 104 21 Footprinted enteritidis Polymer 2 CA 02211174 l997-07-22 WO 96/26440 I?CT~GB96~00~10 Samples contained 5ml buffer (lOmM MOPS pH7.0), 50mg polymer beads, lOOml bacteria (104 cfu/ml). Rotation was carried out for 2 hours followed by settling of beads. Samples of supernatant (lOOml) were drawn and plated for bacterial counting.
In order to demonstrate the increase in specific binding provided by these treatments over the non-specific binding provided using commercially available untreated beads, a comparative test was carried out using Dynabeads available from Dynal A/S PO Box 158.
Skoyen, N0212 Oslo, Norway that had Salronell~ antibodies immobilised upon them.
TABLE 2: Bacterial ~xtraction using antibodies on Dynabeads.
Bacterial speciesConc. added cfu/ml %Extracted S. typhimurium 105 24 E. coli 104 13 S. enteritidis 103 20 L. monocytogenes 104 28 ~ Assays were carried out in accordance with the manufacturers instructions.
CA 022lll74 l997-07-22 E~mele 1~: Attachm~nt of enzymes to Doly~m;nes.
The method of forming a specific binding material shown diagrammatically in Figure 1 and Figure 2 wherein ligand L is lysozyme was carried out by dissolving lysozyme (14.4mg, O.OOlmmol) and polyallylamine.HCl (~ 14,000) (lOOmg-lmmol) in MOPS buffer (50mM, 5ml) and adjusting the pH of the solution to 4.5. A solution of EDC (19.2mg, O.lmmol) in water (lml) was added and the reaction vessel was stirred gently at room temperature overnight with maintenance at pH4.5 throughout. The solution was then dialysed against MOPS buffer (30mM pH6.8, 3 x lOOml) before concentration (Amicon PM10 membrane) and purification by gel filtration (Sephacryl 200; elution with 30mM MOPS, lOOmM KCl, lmM EDTA, pH6.8). Fractions exhibiting UV absorption at 280nm were combined, concentrated (Amicon PM3 membrane) and lyophilised to leave a white powdery solid (50mg).
This material can be used to form the beads of the invention by substitution for the polyallylamine reactants in each case.
Fx~r~le 1~: visualisation of ~rocess with SEM
A solution of 3-[N]-morpholino/propylsulphonic acid (MOPS) buffer (pH
7.8, 0.6N, 250ml) was purged with nitrogen for 10 minutes before addition of adipoyl chloride (1.2ml) in a mixed organic phase contAining dibutyl ether (14.4ml), 1,6-hexanedioldiacrylate (14.4ml), and azobis (isobutyronitrile) (300mg). A suspension of bacteria (T.i~teria ronocytogenes or St~ehylococcus auren~, ethidium bromide stained, 4 x 108cfu.ml~l), in MOPS buffer (50ml), was then added and stirring continued for 3 minutes before dropwise addition of poly(allylamine) solution (0.12N in 0.6N MOPS, pH 7.8, 75ml). The resultant microcapsules with attached bacteria were irradiated (360nm) with stirring for 12 hours to generate solid beads which were filtered, washed and water (3 x lOOml), methanol (3 x lOOml) and air-dried. The beads (5.0g) were then stirred in 1,1,2-trichlorotrifluoroethane (250ml) as a solution of diisocyanato-terminated perfluoropolyether (FOMBLIN Z DISOC 1.5g) in CA 022lll74 l997-07-22 1,1,2-trifluorotrichloroehane (20ml) was added dropwise. Stirring was continued for 3 hours before the reaction was terminated by addition of suspension to methanol (250 ml). After filtration and methanol washing (5 x lOOmL), the beads were refluxed in 6M
HCl/methanol (150ml) to remove the bacteria. "Development" of the exposed lithographic prints was effected by stirring the beads (lOOmg) in pH 4.75 sodium acetate buffer (5ml, 50mM, cont~ining 5mM
MnCl2, 5mM CaCl2, and ethanol (500ml)) with fluorescein isothiocyanate-labelled Concanavalin A (lmg, ~ O.OOOlmmol) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (5mg, 0.025mmol).
At each stage of the procedure the appearance and morphology of the polymers was monitored using a combination of Confocal Laser Scanning Microscopy (CLSM) and Scanning Electron Microscopy (SEM) (Figure 4).
Plate la and lb show the initial polyamide microcapsules, cont~inin~
a liquid organic core, with surface-bound Listeri~ monocyto~enes and StAnhylococclls aurell~ as representative rod-shaped and coccoidal bacteria respectively. The cells were labelled with the fluorescent dye ethidium bromide for this experiment. It is evident from the optical slices shown that the microorganisms were located on the outside of the polymer capsules, and the degree of surface coverage was easily controlled by variation of initial microorganism concentration and polymerization conditions. Photomicrographs of polymeric beads obtained after irradiation of the respective capsules are presented in Plates 2a and 2b. Examination of the surface by SEM
showed a certain degree of variation with regard to position of the bacteria at the surface, with some cells almost completely buried in the outer layer of the polyamide and the majority only slightly embedded in the surface. After removal of the template microorganisms, the presence of deep indentations (100-200nm) was readily apparent in SEM micrographs (Plates 3a and 3b). These "sites" exhibited exact size and shape complementarity to the ~ bacteria. However, to demonstrate the success of our lithographic procedure it was necessary to "develop" the difference in chemical functionality between the now exposed sites and the perfluoropolymer modified surfaces. The beads were therefore reacted with a fluorescent labelled lectin (FITC-Concanavalin A) via l-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) mediated coupling of free amino groups on the unmodified polymer surfaces with carboxyl residues on the lectin. This enabled us to achieve a chemical amplification of the site functionality, visualised by CLSM, but exactly the same procedure can be used for the introduction of a specific ligand (antibodies or lectins) for selective recognition of the template microorganism. The results of this experiment are shown in Plates 4a and 4b where the lithographic image of the cells on the polymeric surface is ~nh~nced and developed through the use of the fluorescent dye.
This experiment clearly shows that it is possible to recreate the shape and size of whole cells employed as templates during multi-component polymer synthesis. The resultant polymeric beads exhibiting functionally anisotroPiC patches, of dimensions defined by the template, can be further modified to adjust the chemistry in the sites and/or to introduce any further recognition elements required for a particular use. The materials obtained are expected to find wide ranging applications in the biomedical field and environmental/food analysis where the rapid, efficient separation and recovery of cells, microorganisms and viruses is of paramount importance. Incorporation of, for example, ferrofluids in the organic core of these polymer particles will enable the exploitation of these materials in diagnostic applications where magnetic separations are already in widespread use.
-
Claims (24)
1. A specific binding material adapted to specifically bind with a target material wherein:
(a) the binding material has areas upon its surface corresponding to the size and/or shape of the target material, (b) the areas of the binding material surface that are not sized or shaped to correspond to the target material have been treated to reduce their ability to bind the target and/or any other material from a liquid phase sample from which it is being specifically selected.
(a) the binding material has areas upon its surface corresponding to the size and/or shape of the target material, (b) the areas of the binding material surface that are not sized or shaped to correspond to the target material have been treated to reduce their ability to bind the target and/or any other material from a liquid phase sample from which it is being specifically selected.
2. A specific binding material as claimed in claim 1 wherein the treatment is carried out when the target material is bound to the binding material.
3. A specific binding material as claimed in claim 1 or claim 2 wherein the treatment removes or masks the species on the binding material surface that cause the target and other materials to become bound.
4. A specific binding material as claimed in claim 3 wherein the species are reacted with an agent such as to attach a silyl or perfluoro group to the material surface.
5. A specific binding material as claimed in any one of the preceding claims wherein the target is a biological target material.
6. A specific binding material as claimed in claim 5 wherein the target is a microorganism, antibody or antigen.
7. A specific binding material as claimed in any one of the preceding claims wherein the material surface has areas sized and shaped to accommodate a substantial part of the target material.
8. A specific binding material as claimed in any one of the preceding claims comprising a polymeric body on which areas corresponding in size and/or shape to the target have been formed.
9. A specific binding material as claimed in claim 8 wherein the areas have a high affinity for binding the target.
10. A specific binding material as claimed in claim 8 or 9 wherein the size and/or shape specific areas of the material has functionalised species or have antibodies or antigens bound to it.
11. A specific binding material as claimed in claim 10 wherein the functionalised species include charge bearing groups.
12. A method for the preparation of a specific binding material as claimed in any one of the preceding claims comprising:
(a) binding a target material to the surface of a preformed binding material which has areas upon its surface corresponding to the size and/or shape of the target material, (b) treating the areas of the binding material surface that are not covered by target material such that they become wholly or partially inactivated with respect to their ability to bind target and non-target materials, (c) removing the target material from that surface.
(a) binding a target material to the surface of a preformed binding material which has areas upon its surface corresponding to the size and/or shape of the target material, (b) treating the areas of the binding material surface that are not covered by target material such that they become wholly or partially inactivated with respect to their ability to bind target and non-target materials, (c) removing the target material from that surface.
13. A method as claimed in claim 12 wherein the binding material used in (a) is adapted such as to be capable of conforming or interacting with the shape or size of the target such that non-target materials not having the desired shape or being too large to fit into or onto the conformed area do not become bound or bind with decreased affinity.
14. A method as claimed in claim 13 wherein the binding material used in (a) is adapted to the shape and size of a target formed by binding a target material to the surface of a material such that the surface of the binding material becomes adapted the size and/or shape of the target material.
15. A method as claimed in claim 13 wherein the binding material used in (a) is adapted to the shape and size of a target by forming a body of the specific binding material in the presence of the target material.
16. A method as claimed in claim 15 wherein the body is formed by polymerising monomers in the presence of the target at target physiological pH and temperature.
17. A method as claimed in claim 15 or claim 16 wherein the formation results in a mirroring of target surface features.
18. A method as claimed in any one of claims 15 to 17 wherein the polymerization is carried out by interfacial reactions using dispersed organic phase in an aqueous matrix.
19. A method as claimed in any one of claims 15 to 18 wherein the monomers are radiation cross-linked to produce the polymer.
20. A method as claimed in any one of claims 12 to 19 wherein the target material is removed from the formed material by subjecting the materials to a high vortex and/or use of acids or alkalis.
21. A specific binding material as claimed in any one of claims 1 to 11 in the form of a bead, capsule, strip, film, membrane or dipstick.
22. Use of a specific binding material as claimed in any one of claims 21 for the purpose of extracting specific target materials from a liquid sample.
23. Use as claimed in claim 22 wherein the specific target material is a microorganism
24. A test kit characterised in that it comprises a specific binding material as claimed in claims 21.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9503429.4A GB9503429D0 (en) | 1995-02-21 | 1995-02-21 | Specific binding materials |
GB9503429.4 | 1995-02-21 | ||
GB9519427.0 | 1995-09-22 | ||
GB9519427A GB2298274A (en) | 1995-02-21 | 1995-09-22 | Specific binders for target materials in which the binder comprises surface areas corresponding to said target material |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2211174A1 true CA2211174A1 (en) | 1996-08-29 |
Family
ID=26306551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002211174A Abandoned CA2211174A1 (en) | 1995-02-21 | 1996-02-21 | Specific binding materials |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0811161A1 (en) |
JP (1) | JPH11500824A (en) |
AU (1) | AU4728196A (en) |
CA (1) | CA2211174A1 (en) |
WO (1) | WO1996026440A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL158430A0 (en) * | 2001-04-16 | 2004-05-12 | Semorex Inc | Selective covalent-binding compounds having therapeutic diagnostic and analytical applications |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0089425B1 (en) * | 1982-03-19 | 1985-12-11 | Uop Inc. | Method for the preparation of integral shaped replications of shaped, porous and dissolvable materials for use as adsorbents in fixed bed adsorption processes |
US4748042A (en) * | 1987-03-31 | 1988-05-31 | V-Tech, Inc. | Method and apparatus for imprinting membranes with patterns of antibody |
US5310648A (en) * | 1991-02-01 | 1994-05-10 | California Institute Of Technology | Composition of matter comprising an imprinted matrix exhibiting selective binding interactions through chelated metals |
SE9102622L (en) * | 1991-09-06 | 1993-03-07 | Klaus Mosbach | MAKE ASTADCOMMATIC SPECIFIC ADSORPTION MATERIAL APPLICABLE TO BIOLOGICAL MACROMOLECULES THROUGH PREPARATION OF IMMOBILIZABLE TO THE MACROMOLECYL IN QUESTION BINDING FUNCTIONAL GROUPS |
-
1996
- 1996-02-21 CA CA002211174A patent/CA2211174A1/en not_active Abandoned
- 1996-02-21 WO PCT/GB1996/000410 patent/WO1996026440A1/en not_active Application Discontinuation
- 1996-02-21 AU AU47281/96A patent/AU4728196A/en not_active Abandoned
- 1996-02-21 JP JP8525502A patent/JPH11500824A/en active Pending
- 1996-02-21 EP EP96903137A patent/EP0811161A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPH11500824A (en) | 1999-01-19 |
WO1996026440A1 (en) | 1996-08-29 |
EP0811161A1 (en) | 1997-12-10 |
AU4728196A (en) | 1996-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69027803T2 (en) | Polymer carrier | |
Kuhn et al. | Selective binding of antibiotics using magnetic molecular imprint polymer (MMIP) networks prepared from vinyl-functionalized magnetic nanoparticles | |
DE19528029B4 (en) | Magnetic polymer particles based on polyvinyl alcohol, process for their preparation and use | |
US5814687A (en) | Magnetic polymer particle and process for manufacturing the same | |
US6783962B1 (en) | Particulate material for purification of bio-macromolecules | |
US9447232B2 (en) | Carrier polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same | |
US20100291224A1 (en) | Nanostructures, methods of preparing and uses thereof | |
EP1312671B1 (en) | Magnetic particles having lower limit critical solution temperature | |
US20090099342A1 (en) | Process for Preparing Composite Particles, Composite Particles Obtained, and Their Use in a Diagnostic Test | |
JP4324101B2 (en) | Binding of target substance | |
CN103506093B (en) | Magnetic dual-template protein molecule imprinted nano particle and preparation method thereof | |
CN111285951A (en) | Lipase/polyion liquid-styrene microsphere/hydrogel catalytic material and preparation method and application thereof | |
Doostmohammadi et al. | Molecularly imprinted polymer (MIP) based core-shell microspheres for bacteria isolation | |
WO2000057982A1 (en) | Fluidised bed purification of bio-macromolecules such as plasmid dna, chromosomal dna, rna, viral dna, bacteria and viruses | |
DE60031826T2 (en) | Separation of viruses and detection of viruses | |
US4170685A (en) | Polyvinyl pyridine microspheres | |
CA2211174A1 (en) | Specific binding materials | |
JP4788056B2 (en) | Virus concentration material | |
EP3274069B1 (en) | Method of purifying a biological composition and article therefor | |
Pichot et al. | Polymer colloids for biomedical and pharmaceutical applications | |
GB2298274A (en) | Specific binders for target materials in which the binder comprises surface areas corresponding to said target material | |
JP4903449B2 (en) | MAGNETIC COMPLEX AND MANUFACTURING METHOD THEREOF, METHOD FOR REMOVING SUBSTANCE HAVING MANNOSE ON SURFACE AND CONCENTRATION METHOD FOR MATERIAL HAVING MANNOSE ON SURFACE | |
Shah et al. | Molecularly imprinted polymer particles and beads: a survey of modern synthetic techniques | |
JP2002125695A (en) | Method for detecting microorganism and substance derived from organism | |
CN102363624B (en) | Endotoxin removal using two nucleophilic-shell nanoadsorbents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |